search
Back to results

Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity (MACRONUTR)

Primary Purpose

Metabolic Syndrome X, Liver Diseases

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
diet intervention
Sponsored by
University of Lausanne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Metabolic Syndrome X focused on measuring fructose, dietary lipids, dietary proteins, hepatic steatosis, insulin resistance, Healthy humans, overweight humans, obese humans

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Males and females
  • Age 18-40
  • Informed consent obtained
  • Subgroup with overweight (body mass index [BMI] > 25)
  • Subgroup with family history of type 2 diabetes mellitus

Exclusion Criteria:

  • Smokers
  • Alcohol intake > 30g/day
  • Drug abuse
  • Diabetes mellitus
  • Any concurrent medication
  • Having a pacemaker
  • History of orthopedic surgery
  • History of metal foreign bodies

Sites / Locations

  • Centre Hospitalier Universitaire Vaudois

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

normal weight male high fructose diet

offsprings of T2DM high fructose diet

normal weight subjects high fat diet

Normal weight high fat+protein diet

Arm Description

Effects of diet intervention " high fructose" in normal weight subjects

Effect of diet intervention "high fructose" in healthy non-obese offsprings of patients with type 2 diabetes

effects of diet intervention "high fat" in healthy male subjects

effect of diet intervention "high fat + protein" subjects in healthy male subjects

Outcomes

Primary Outcome Measures

plasma triglycerides
intra-hepatic lipids
insulin mediated glucose disposal

Secondary Outcome Measures

lipid oxidation
plasma beta-hydroxybutyrate
gene expression in skeletal muscle and adipose tissue

Full Information

First Posted
August 30, 2007
Last Updated
June 12, 2018
Sponsor
University of Lausanne
search

1. Study Identification

Unique Protocol Identification Number
NCT00523562
Brief Title
Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity
Acronym
MACRONUTR
Official Title
Study of the Role of Insulin Resistance in the Pathogenesis of the Metabolic Syndrome and of Non-alcoholic Steatohepatitis
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
July 2006 (undefined)
Primary Completion Date
April 2008 (Actual)
Study Completion Date
January 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Lausanne

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess how the macronutrient composition of the diet effects lipid and glucose metabolism intrahepatic lipids insulin sensitivity in healthy lean subjects and in subjects with a high metabolic risk (ie overweight and offsprings of patients with type 2 diabetes mellitus).
Detailed Description
The study is aimed at assessing the effects of changes in total energy, sugars, lipids, and protein intake on intrahepatic lipids, plasma lipids, and hepatic and whole body insulin resistance in lean men and women with no family history of diabetes overweight men and women lean men with a family history of type 2 diabetes Subjects are studied after a 6-day period of isocaloric diet with 100% calorie requirement, of which 55% carbohydrate, 15% protein, and 30% fat) the same isocaloric diet supplemented with 3g/kg body weight/day fructose hypercaloric high fat diet with 130% energy requirement, of which 55% carbohydrate, 15% protein, 60% fat hypercaloric high fat+protein diet with 145% energy requirement, of which 55% carbohydrate, 30% protein, 60% fat Measurements performed after 6 days on each diet include intrahepatic and intramyocellular lipids (1H-MRS) hepatic and whole body insulin sensitivity (hyperinsulinemic-euglycemic clamp) body weight plasma concentrations of hormones and substrates gene expression profile in skeletal muscle (vastus lateralis) and adipose tissue (subcutaneous abdominal)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome X, Liver Diseases
Keywords
fructose, dietary lipids, dietary proteins, hepatic steatosis, insulin resistance, Healthy humans, overweight humans, obese humans

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
41 (Actual)

8. Arms, Groups, and Interventions

Arm Title
normal weight male high fructose diet
Arm Type
Experimental
Arm Description
Effects of diet intervention " high fructose" in normal weight subjects
Arm Title
offsprings of T2DM high fructose diet
Arm Type
Experimental
Arm Description
Effect of diet intervention "high fructose" in healthy non-obese offsprings of patients with type 2 diabetes
Arm Title
normal weight subjects high fat diet
Arm Type
Experimental
Arm Description
effects of diet intervention "high fat" in healthy male subjects
Arm Title
Normal weight high fat+protein diet
Arm Type
Experimental
Arm Description
effect of diet intervention "high fat + protein" subjects in healthy male subjects
Intervention Type
Other
Intervention Name(s)
diet intervention
Intervention Description
controlled hypercaloric high fructose, high fat, or high fat/high protein diet
Primary Outcome Measure Information:
Title
plasma triglycerides
Time Frame
6 days
Title
intra-hepatic lipids
Time Frame
6 days
Title
insulin mediated glucose disposal
Time Frame
6 days
Secondary Outcome Measure Information:
Title
lipid oxidation
Time Frame
6 days
Title
plasma beta-hydroxybutyrate
Time Frame
6 days
Title
gene expression in skeletal muscle and adipose tissue
Time Frame
6 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Males and females Age 18-40 Informed consent obtained Subgroup with overweight (body mass index [BMI] > 25) Subgroup with family history of type 2 diabetes mellitus Exclusion Criteria: Smokers Alcohol intake > 30g/day Drug abuse Diabetes mellitus Any concurrent medication Having a pacemaker History of orthopedic surgery History of metal foreign bodies
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luc Tappy, MD
Organizational Affiliation
University of Lausanne
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Universitaire Vaudois
City
Lausanne
ZIP/Postal Code
CH-1011
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
19710199
Citation
Bortolotti M, Kreis R, Debard C, Cariou B, Faeh D, Chetiveaux M, Ith M, Vermathen P, Stefanoni N, Le KA, Schneiter P, Krempf M, Vidal H, Boesch C, Tappy L. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr. 2009 Oct;90(4):1002-10. doi: 10.3945/ajcn.2008.27296. Epub 2009 Aug 26.
Results Reference
derived
PubMed Identifier
19403641
Citation
Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009 Jun;89(6):1760-5. doi: 10.3945/ajcn.2008.27336. Epub 2009 Apr 29.
Results Reference
derived

Learn more about this trial

Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity

We'll reach out to this number within 24 hrs